GLP-1 pathway | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

64,097 results for “GLP-1 pathway”

Trials

View all 36940 →

GIP and GLP-1 in Type 1 Diabetes

10 participants · First posted Dec 3, 2012

Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

140 participants · First posted Jul 30, 2026

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

240 participants · First posted Jul 30, 2026

Drugs

View all 7583 →

rHSA-GLP-1

GLP-1 RA

GLP-1-21104

Organizations

View all 1449 →

Pathway Therapeutics, Inc.

United States

NHI-1

United States

Xi'an No.1 Hospital

China

News

View all 18125 →

MindWalk Unveils AI-Designed Dual-Pathway GLP-1 Regimen Targeting $60B Longevity Market

4Moving Biotech Initiates Phase 2a Trial of First-in-Class GLP-1 Therapy for Knee Osteoarthritis

Zealand Pharma Explores Direct-to-Consumer Sales for Novel Amylin-Based Obesity Drug Petrelintide

Page 1 of 6410